Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma
Clinical trial NCT00027625 · COMPLETED
Trial details
- NCT number
- NCT00027625
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-28
- Primary completion
- 2005-03-17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.